Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9198
Revised: October 26, 2013
Accepted: November 12, 2013
Published online: December 28, 2013
Currently, alcoholic cirrhosis is the second leading indication for liver transplantation in the United States and Europe. The quality of life and survival after a liver transplantation (LT) in patients with alcoholic liver disease (ALD) are similar to those in patients with other cirrhosis etiologies. The alcoholic relapse rate after a LT varies from 10%-50%, and these relapse patients are the ones who present a reduced long-term survival, mainly due to cardiovascular diseases and the onset of de novo neoplasms, including lung and upper aerodigestive tract. Nearly 40% of ALD recipients resume smoking and resume it early post-LT. Therefore, our pre-and post-LT follow-up efforts regarding ALD should be focused not only on alcoholic relapse but also on treating and avoiding other modifiable risk factors such as tobacco. The psychiatric and psychosocial pre-LT evaluation and the post-LT follow-up with physicians, psychiatrists and addiction specialists are important for reversing these problems because these professionals help to identify patients at risk for relapse as well as those patients who have relapsed, thus enabling responsive actions.
Core tip: Transplanted alcoholic liver disease (ALD) patients who relapse have an increased long-term mortality due to cardiovascular pathologies and the onset of de novo neoplasms, including lung and upper aerodigestive tract cancer. Nearly 40% of ALD recipients resume smoking and resume it early post-liver transplantation (LT). Therefore, our pre-and post-LT follow-up efforts regarding alcoholic liver disease should be focused not only on alcoholic relapse but also on treating and avoiding other modifiable risk factors such as tobacco. The psychiatric and psychosocial pre-LT evaluation and the post-LT follow-up with physicians, psychiatrists and addiction specialists are important for reversing these problems.